Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNew study locations added: Barcelona, Murcia, and Valencia; page revision updated to v3.3.3.SummaryDifference0.4%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2; no user-facing changes to study data or interface are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page removed a general funding/operating-status notice previously shown on the site, which does not affect the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedThe two screenshots indicate the same study record with only minor formatting/layout updates; core details such as eligibility criteria, primary/secondary outcomes, enrollment numbers, and listed locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check95 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.